Mink Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Mink Therapeutics

09/08/2024 19:53

* Mink Therapeutics Inc  INKT.OQ   INKT.O  is expected
to show no
change in quarterly revenue when it reports  results on August
13 for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Mink Therapeutics Inc is
for a
loss of 10 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mink
Therapeutics
Inc is $8.00​, above​ its last closing price of $0.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.16       -0.15      -0.11     Beat    28.3
 Jan. 1 2024               -0.15      -0.16     Missed  -4.3
 Jan. 1 0001   -0.18       -0.18      -0.15     Beat    17.8​
 Jun. 30 2023  -0.19       -0.20      -0.18     Beat    8.9
 ​​Mar.        -0.25       -0.24      -0.17     Beat    28.4
 31 2023                                                
 Dec. 31 2022              -0.21      -0.23     Missed  -9.5​
 Sep. 30 2022  -0.23       -0.23      -0.19     Beat    18.3
 Jun. 30 2022  -0.24       -0.24      -0.18     Beat    25
 This summary was machine generated August 9 at 18:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)